Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transgenic rabbits expressing human apolipoprotein (a).

J Fan1, T Watanabe

  • 1Department of Pathology, Institute of Basic Medical Sciences, University of Tsukuba, Japan. j-lfan@md.tsukuba.ac.jp

Journal of Atherosclerosis and Thrombosis
|June 27, 2001
PubMed
Summary

High levels of lipoprotein (a) are linked to heart disease, but studying it is difficult because humans and primates are the only natural carriers. Researchers created transgenic rabbits that produce human apolipoprotein (a), which successfully combines with rabbit proteins to mimic human lipoprotein (a) particles. This new model offers a better way to investigate how these particles contribute to artery disease compared to previous mouse models.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

miR-216a rescues dexamethasone suppression of osteogenesis, promotes osteoblast differentiation and enhances bone formation, by regulating c-Cbl-mediated PI3K/AKT pathway.

Cell death and differentiation·2015
Same author

Distributions of topological observables in inclusive three- and four-jet events in pp collisions at [Formula: see text][Formula: see text].

The European physical journal. C, Particles and fields·2015
Same author

Evidence for Collective Multiparticle Correlations in p-Pb Collisions.

Physical review letters·2015
Same author

Constraints on parton distribution functions and extraction of the strong coupling constant from the inclusive jet cross section in pp collisions at [Formula: see text][Formula: see text].

The European physical journal. C, Particles and fields·2015
Same author

Search for a standard model Higgs boson produced in association with a top-quark pair and decaying to bottom quarks using a matrix element method.

The European physical journal. C, Particles and fields·2015
Same author

Search for dark matter, extra dimensions, and unparticles in monojet events in proton-proton collisions at [Formula: see text][Formula: see text].

The European physical journal. C, Particles and fields·2015

Area of Science:

  • Cardiovascular research within human apolipoprotein (a) pathophysiology
  • Molecular genetics and animal model development

Background:

High concentrations of lipoprotein (a) represent a significant independent hazard for coronary artery disease, stroke, and vessel narrowing. Scientific comprehension regarding the genetics and metabolic pathways of this particle has expanded over recent decades. Nevertheless, the exact biological processes through which this atherogenic molecule drives arterial plaque formation remain poorly defined. This knowledge gap persists because the specific protein component, apolipoprotein (a), exists naturally only in humans and primates. Prior research has shown that transgenic mouse models provide some utility for investigating these particles. However, that uncertainty drove the need for better systems, as mouse proteins fail to bind human apolipoprotein (a) correctly. No prior work had resolved the inability of rodents to assemble these specific lipoprotein complexes effectively. Consequently, investigators sought to develop a more suitable mammalian platform for studying these complex human particles.

Purpose Of The Study:

Keywords:
atherosclerosis modellipoprotein metabolismtransgenic animal modelsatherogenic lipoproteins

Frequently Asked Questions

The researchers propose that the transgenic rabbits successfully assemble lipoprotein (a) particles because human apolipoprotein (a) binds to rabbit apolipoprotein B. This interaction occurs within the plasma, resulting in particles found in the 1.02 to 1.10 g/ml density range, unlike the failed assembly observed in transgenic mice.

The study utilizes transgenic rabbits as a novel animal model. This approach is necessary because, unlike mice, rabbits possess the physiological capacity to associate human apolipoprotein (a) with their endogenous apolipoprotein B, effectively mimicking the human lipoprotein (a) particle structure.

The researchers state that the rabbit model is necessary because the human protein cannot bind to murine apolipoprotein B. This technical limitation prevents the formation of complete lipoprotein (a) particles in mice, rendering them less suitable for studying the full pathophysiology of the human molecule.

Related Experiment Videos

The aim of this study is to generate and validate transgenic rabbits that express human apolipoprotein (a). Researchers sought to address the lack of appropriate animal models for studying the pathophysiology of lipoprotein (a). This specific problem arises because the human protein does not form the necessary particles in common laboratory rodents. The motivation for this work stems from the need to understand how this atherogenic lipoprotein contributes to arterial disease. No prior work had successfully resolved the issue of species-specific protein incompatibility in mouse models. This gap drove the investigators to utilize rabbits as a more suitable host for human protein expression. The study intends to demonstrate that these transgenic rabbits can efficiently assemble human-like lipoprotein (a) particles. By establishing this model, the researchers hope to provide a new platform for investigating the development of atherosclerosis.

Main Methods:

The research team employed a transgenic approach to introduce human genetic material into rabbits. This review approach focuses on the generation and characterization of these modified animals. Scientists utilized density gradient ultracentrifugation to isolate and analyze the plasma lipoprotein fractions. The team quantified the association between human apolipoprotein (a) and endogenous rabbit apolipoprotein B. They compared the assembly efficiency in these rabbits against previously established transgenic mouse models. The investigators performed protein analysis to confirm the presence and density distribution of the newly formed particles. This experimental design allowed for the assessment of whether the human protein could successfully integrate into the rabbit circulatory system. The researchers evaluated the plasma samples to determine the percentage of human protein successfully bound to rabbit carrier proteins.

Main Results:

The strongest finding from the literature is that transgenic rabbits exhibit efficient assembly of lipoprotein (a) particles. Approximately 80% of the human apolipoprotein (a) in the plasma of these animals associates with rabbit apolipoprotein B. These particles are contained within the density range of 1.02 to 1.10 g/ml. This result contrasts with transgenic mice, where the human protein fails to bind to murine apolipoprotein B. The data indicate that the rabbit circulatory environment is compatible with the formation of these human-like complexes. The researchers report that this successful assembly provides a functional animal model for further investigation. These findings demonstrate that the rabbit system overcomes the structural limitations inherent in rodent models. The evidence confirms that the transgenic rabbits effectively mimic the human lipoprotein (a) profile in the plasma.

Conclusions:

The authors propose that their transgenic rabbit line serves as a viable animal model for exploring human lipoprotein (a) dynamics. This synthesis suggests that the successful assembly of these particles in rabbits overcomes limitations seen in rodent systems. The findings imply that the rabbit circulatory environment supports the necessary interactions between human apolipoprotein (a) and endogenous apolipoprotein B. These results indicate that the majority of the expressed protein successfully integrates into the expected density fractions. The researchers conclude that this model provides a platform to investigate the pathophysiology of these atherogenic particles. This review of the evidence highlights the potential for future studies to utilize this rabbit model for cardiovascular research. The authors suggest that this approach facilitates a deeper understanding of how these particles contribute to disease development. This work establishes a foundation for testing therapeutic interventions targeting these specific lipoprotein complexes in a controlled setting.

The authors analyze plasma density fractions to determine the role of apolipoprotein (a). They report that approximately 80% of the human protein associates with rabbit apolipoprotein B, confirming the successful formation of lipoprotein (a) particles within the 1.02 to 1.10 g/ml density range.

The researchers measure the association of human apolipoprotein (a) with rabbit apolipoprotein B. They observe that 80% of the human protein is successfully incorporated into lipoprotein (a) particles, a phenomenon that does not occur in transgenic mouse models due to species-specific protein incompatibility.

The authors propose that this transgenic rabbit model can be used to study human lipoprotein (a). They imply that this system allows for the investigation of the development of atherosclerosis, which remains unclear due to the lack of appropriate animal models in prior research.